.svg){kind=small}
Join us in Vienna for a comprehensive exploration of translational heart failure research. This prestigious event brings together researchers, clinicians, and industry leaders to discuss the latest advancements in understanding and treating heart failure. Key topics include novel therapeutic targets, patient care innovations, and interdisciplinary collaborations. Our team will share insights from our latest research and engage in discussions on overcoming challenges in heart failure management. Schedule a meeting with us to exchange ideas and explore collaborative opportunities.
-min.jpg)
.jpg)
Latest news
Richmond Appoints Lisa Campbell as Director of Regulatory Strategy
April 23, 2025
Richmond Pharmacology is pleased to announce the appointment of Lisa Campbell as Director of Regulatory Strategy
Read moreVon Willebrand Disease – First Stage of Hemab Therapeutics’ Trial Completed and New Patients Invited to Enrol
April 2, 2025
Richmond has completed dosing the first cohort of patients in Velora Pioneer, a phase 1/2 clinical trial investigating Hemab...
Read moreEvents
Swiss Biotech Day 2025
5–6 May 2025
Richmond Pharmacology is pleased to confirm our participation at Swiss Biotech Day 2025
View event
